Report Detail

Request for Sample of this report

Pharma & Healthcare Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2022

  • RnM4438766
    • |
  • 11 May, 2022
    • |
  • Global
    • |
  • 85 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Summary:

Industry Insights
Due to the COVID-19 pandemic, the global Prothrombin Complex Concentrate (PCC) Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Prothrombin Complex Concentrate (PCC) Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Prothrombin Complex Concentrate (PCC) Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
500 IU/Vial accounting for % of the Prothrombin Complex Concentrate (PCC) Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hemophilia B segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Prothrombin Complex Concentrate (PCC) Drug include Takeda, CSL Behring GmbH, Grifols Biologicals, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Prothrombin Complex Concentrate (PCC) Drug in 2021.
This report focuses on Prothrombin Complex Concentrate (PCC) Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Prothrombin Complex Concentrate (PCC) Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Prothrombin Complex Concentrate (PCC) Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Takeda
CSL Behring GmbH
Grifols Biologicals
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Frequently Asked Questions
Which product segment grabbed the largest share in the Prothrombin Complex Concentrate (PCC) Drug market?
How is the competitive scenario of the Prothrombin Complex Concentrate (PCC) Drug market?
Which are the key factors aiding the Prothrombin Complex Concentrate (PCC) Drug market growth?
Which are the prominent players in the Prothrombin Complex Concentrate (PCC) Drug market?
Which region holds the maximum share in the Prothrombin Complex Concentrate (PCC) Drug market?
What will be the CAGR of the Prothrombin Complex Concentrate (PCC) Drug market during the forecast period?
Which application segment emerged as the leading segment in the Prothrombin Complex Concentrate (PCC) Drug market?
What key trends are likely to emerge in the Prothrombin Complex Concentrate (PCC) Drug market in the coming years?
What will be the Prothrombin Complex Concentrate (PCC) Drug market size by 2028?
Which company held the largest share in the Prothrombin Complex Concentrate (PCC) Drug market?


Table of Contents

    1 Prothrombin Complex Concentrate (PCC) Drug Market Overview

    • 1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
    • 1.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
      • 1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 500 IU/Vial
      • 1.2.3 600 IU/Vial
      • 1.2.4 1000 IU/Vial
      • 1.2.5 Others
    • 1.3 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
      • 1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Comparison by Application: (2022-2028)
      • 1.3.2 Hemophilia B
      • 1.3.3 Vitamin K Deficiency
      • 1.3.4 Others
    • 1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts
      • 1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2028
      • 1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2028
      • 1.4.3 Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers

    • 2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Prothrombin Complex Concentrate (PCC) Drug Manufacturing Sites, Area Served, Product Type
    • 2.5 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
      • 2.5.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
      • 2.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario by Region

    • 3.1 Global Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
      • 3.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
      • 3.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
      • 3.4.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country
      • 3.4.2 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region
      • 3.5.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
      • 3.6.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country
      • 3.6.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country
      • 3.7.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Prothrombin Complex Concentrate (PCC) Drug Historic Market Analysis by Type

    • 4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)
    • 4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2022)
    • 4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2022)

    5 Global Prothrombin Complex Concentrate (PCC) Drug Historic Market Analysis by Application

    • 5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)
    • 5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2022)
    • 5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Takeda
      • 6.1.1 Takeda Corporation Information
      • 6.1.2 Takeda Description and Business Overview
      • 6.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.1.5 Takeda Recent Developments/Updates
    • 6.2 CSL Behring GmbH
      • 6.2.1 CSL Behring GmbH Corporation Information
      • 6.2.2 CSL Behring GmbH Description and Business Overview
      • 6.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.2.5 CSL Behring GmbH Recent Developments/Updates
    • 6.3 Grifols Biologicals
      • 6.3.1 Grifols Biologicals Corporation Information
      • 6.3.2 Grifols Biologicals Description and Business Overview
      • 6.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.3.5 Grifols Biologicals Recent Developments/Updates
    • 6.4 Octapharma
      • 6.4.1 Octapharma Corporation Information
      • 6.4.2 Octapharma Description and Business Overview
      • 6.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.4.5 Octapharma Recent Developments/Updates
    • 6.5 Hualan Biological
      • 6.5.1 Hualan Biological Corporation Information
      • 6.5.2 Hualan Biological Description and Business Overview
      • 6.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.5.5 Hualan Biological Recent Developments/Updates
    • 6.6 Meheco Xinxing Pharma
      • 6.6.1 Meheco Xinxing Pharma Corporation Information
      • 6.6.2 Meheco Xinxing Pharma Description and Business Overview
      • 6.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
      • 6.6.5 Meheco Xinxing Pharma Recent Developments/Updates

    7 Prothrombin Complex Concentrate (PCC) Drug Manufacturing Cost Analysis

    • 7.1 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
    • 7.4 Prothrombin Complex Concentrate (PCC) Drug Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Prothrombin Complex Concentrate (PCC) Drug Distributors List
    • 8.3 Prothrombin Complex Concentrate (PCC) Drug Customers

    9 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics

    • 9.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
    • 9.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
    • 9.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
    • 9.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints

    10 Global Market Forecast

    • 10.1 Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Prothrombin Complex Concentrate (PCC) Drug by Type (2023-2028)
    • 10.2 Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Prothrombin Complex Concentrate (PCC) Drug by Application (2023-2028)
    • 10.3 Prothrombin Complex Concentrate (PCC) Drug Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Prothrombin Complex Concentrate (PCC) Drug by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Prothrombin Complex Concentrate (PCC) Drug by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on Prothrombin Complex Concentrate (PCC) Drug. Industry analysis & Market Report on Prothrombin Complex Concentrate (PCC) Drug is a syndicated market report, published as Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2022. It is complete Research Study and Industry Analysis of Prothrombin Complex Concentrate (PCC) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$2,900.00
      		$5,800.00
      		2,328.70
      		4,657.40
      		2,711.50
      		5,423.00
      		449,877.00
      		899,754.00
      		241,715.00
      		483,430.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo